From: p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
Characteristics | No of patients | % of patients |
---|---|---|
Sex | ||
 Male | 69 | 51.1 |
 Female | 66 | 48.9 |
Age | ||
  < 60 | 55 | 40.7 |
  ≥ 60 | 80 | 59.3 |
Primary site | ||
 Anus | 2 | 1.5 |
 Brain | 7 | 5.2 |
 Breast | 6 | 4.4 |
 Large intestine | 107 | 79.3 |
 Lung | 2 | 1.5 |
 Ovary | 6 | 4.4 |
 Small intestine | 1 | 0.7 |
 Stomach | 2 | 1.5 |
 Unknown | 2 | 1.5 |
Diagnosis | ||
 Adenocarcinoma | 106 | 78.5 |
 Carcinoma | 2 | 1.5 |
 Endometroid adenocarcinioma | 1 | 0.7 |
 Gastrointestinal stromal tumor | 1 | 0.7 |
 Glioblastoma | 7 | 5.2 |
 Invasive ductal carcinoma | 6 | 4.4 |
 Malignant brenner tumor | 1 | 0.7 |
 Mucinous aadenocarcinoma | 6 | 4.4 |
 Papillary serous carcinoma | 4 | 3.0 |
 Squamous cell carcinoma | 1 | 0.7 |
Procedure | ||
 Resection | 125 | 92.6 |
 Excision | 5 | 3.7 |
 Biopsy | 5 | 3.7 |
Neoadjuvant treatment | ||
 Yes | 26 | 19.3 |
 No | 109 | 80.7 |